Cargando…

Correction: A New Recombinant BCG Vaccine Induces Specific Th17 and Th1 Effector Cells with Higher Protective Efficacy against Tuberculosis

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266645/
http://dx.doi.org/10.1371/journal.pone.0116033
_version_ 1782349039433416704
collection PubMed
description
format Online
Article
Text
id pubmed-4266645
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-42666452014-12-26 Correction: A New Recombinant BCG Vaccine Induces Specific Th17 and Th1 Effector Cells with Higher Protective Efficacy against Tuberculosis PLoS One Correction Public Library of Science 2014-12-15 /pmc/articles/PMC4266645/ http://dx.doi.org/10.1371/journal.pone.0116033 Text en © 2014 The PLOS ONE Staff http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Correction
Correction: A New Recombinant BCG Vaccine Induces Specific Th17 and Th1 Effector Cells with Higher Protective Efficacy against Tuberculosis
title Correction: A New Recombinant BCG Vaccine Induces Specific Th17 and Th1 Effector Cells with Higher Protective Efficacy against Tuberculosis
title_full Correction: A New Recombinant BCG Vaccine Induces Specific Th17 and Th1 Effector Cells with Higher Protective Efficacy against Tuberculosis
title_fullStr Correction: A New Recombinant BCG Vaccine Induces Specific Th17 and Th1 Effector Cells with Higher Protective Efficacy against Tuberculosis
title_full_unstemmed Correction: A New Recombinant BCG Vaccine Induces Specific Th17 and Th1 Effector Cells with Higher Protective Efficacy against Tuberculosis
title_short Correction: A New Recombinant BCG Vaccine Induces Specific Th17 and Th1 Effector Cells with Higher Protective Efficacy against Tuberculosis
title_sort correction: a new recombinant bcg vaccine induces specific th17 and th1 effector cells with higher protective efficacy against tuberculosis
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266645/
http://dx.doi.org/10.1371/journal.pone.0116033
work_keys_str_mv AT correctionanewrecombinantbcgvaccineinducesspecificth17andth1effectorcellswithhigherprotectiveefficacyagainsttuberculosis